EC Number   |
Ki Value [mM] |
Ki Value maximum [mM] |
Inhibitor |
Reference |
|---|
    3.1.8.1 | -999 |
- |
more |
in vivo and in vitro inhibition kinetic analysis, overview |
678489 |
| 3.1.8.1 | 0.0003 |
- |
6,7-dihydroxy-3-(3-methylphenyl)-2H-chromen-2-one |
pH 10.5, 37°C |
728992 |
| 3.1.8.1 | 0.001 |
- |
6,7-dihydroxy-3-(4-methylphenyl)-2H-chromen-2-one |
pH 10.5, 37°C |
728992 |
| 3.1.8.1 | 0.0012 |
- |
cefazolin |
pH 8.0, 37°C, serum PON1, versus paraoxon |
678489 |
| 3.1.8.1 | 0.008 |
- |
6,7-dihydroxy-3-(2-methylphenyl)-2H-chromen-2-one |
pH 10.5, 37°C |
728992 |
| 3.1.8.1 | 0.009 |
- |
lornoxicam |
in 50 mM glycine/NaOH, pH 10.5, 1 mM CaCl2, at 25°C |
709291 |
| 3.1.8.1 | 0.026 |
- |
gentamycin sulfate |
pH 8.0, 37°C, serum PON1 |
678489 |
| 3.1.8.1 | 0.041 |
- |
palmitoyl-lysophosphatidylglycerol |
pH 7.4, 25°C |
681730 |
| 3.1.8.1 | 0.052 |
- |
ZnCl2 |
Co2+-PTE, at pH 8.5 and 30°C, with paraoxon as substrate |
709292 |
| 3.1.8.1 | 0.059 |
- |
etomidate |
in 50 mM glycine/NaOH (pH 10.5) containing 1 mM CaCl2, at 25°C |
691848 |
